| symbol,module,role,target_to_intervention_score_100,tractability_class,model,primary_assay,chembl_target_id,pdb_count,alphafold_url,recommended_next_experiment
|
| SNCA,alpha-synuclein aggregation and propagation,central PD pathology target,97.0,highest-priority intervention target,SNCA triplication/A53T iPSC dopaminergic neurons or alpha-synuclein PFF model,"pS129 alpha-synuclein, aggregate load, synaptic/neurite phenotypes",CHEMBL6152,165,https:
|
| GLP1R,metabolic and GLP-1 receptor signalling,repurposing target with phase 2 PD signals,94.0,highest-priority intervention target,dopaminergic neuron stress model with metabolic/inflammatory co-culture,"neuronal survival, inflammatory cytokines, mitochondrial respiration",CHEMBL1784,56,https:
|
| LRRK2,LRRK2 kinase and lysosomal stress,genetically anchored kinase target,90.0,highest-priority intervention target,LRRK2 G2019S or R1441C iPSC-derived dopaminergic neurons,"phospho-Rab10/Rab12, lysosomal morphology, neurite survival",CHEMBL1075104,0,https:
|
| GBA1,GBA1 lysosome/autophagy,lysosomal enzyme and PD risk gene,90.0,highest-priority intervention target,GBA1-mutant iPSC dopaminergic neurons and macrophage/microglia-like cells,"glucocerebrosidase activity, lysosomal pH, alpha-synuclein burden",CHEMBL2179,0,https:
|
| SLC6A3,dopaminergic synapse,dopamine transporter marker and dopaminergic phenotype readout,88.0,highest-priority intervention target,iPSC dopaminergic neuron maturation/readout assay,"DAT expression/function, dopamine uptake, neuron identity QC",CHEMBL238,7,https:
|
| TLR2,innate immune signalling,Reactome-highlighted innate immune receptor,85.6,highest-priority intervention target,iPSC-derived microglia and neuron-microglia co-culture,"TNF/IL6/IL1B release, NF-kB activation, neuronal toxicity",CHEMBL3301399,7,https:
|
| IL17A,IL-17 inflammatory signalling,Reactome-highlighted cytokine pathway node,82.0,highest-priority intervention target,microglia/astrocyte inflammatory co-culture,"IL-17 response genes, cytokine release, neuronal stress markers",CHEMBL3390822,36,https:
|
| PINK1,mitochondrial quality control,mitophagy kinase and recessive PD gene,78.7,highest-priority intervention target,PINK1 knockout iPSC dopaminergic neurons,"mitophagy reporter, mitochondrial membrane potential, ATP/ROS",CHEMBL3337330,3,https:
|
| NTRK1,NTRK/neurotrophin signalling,Reactome-highlighted trophic signalling node,78.0,highest-priority intervention target,dopaminergic neuron survival/trophic support model,"neurite length, survival, phospho-ERK/AKT",CHEMBL2815,0,https:
|
| MAPK1,MAP kinase activation,Reactome-highlighted signalling hub,78.0,highest-priority intervention target,stress-response assay in neurons and microglia,"phospho-ERK, inflammatory/stress response, toxicity counterscreen",CHEMBL4040,0,https:
|
| NOD2,NOD1/2 inflammatory signalling,Reactome-highlighted innate immune sensor,75.0,strong validation target,iPSC-derived microglia or monocyte-derived macrophages,"NOD ligand response, cytokines, inflammasome-related markers",CHEMBL1293266,0,https:
|
| NDUFS3,mitochondrial oxidative phosphorylation,complex I pathway marker from pilot omics,66.5,strong validation target,iPSC dopaminergic neuron mitochondrial stress model,"Seahorse OCR, complex I activity, ATP/ROS",CHEMBL6067008,0,https:
|
| LAMP2,lysosome/autophagy,lysosomal/autophagy marker,66.5,strong validation target,iPSC dopaminergic neurons with lysosomal stress,"LC3/p62 flux, lysosomal pH, autophagosome clearance",CHEMBL5465542,0,https:
|
| MYD88,innate immune signalling,TLR adaptor in Reactome MyD88/MAL cascade,64.2,strong validation target,iPSC-derived microglia inflammatory challenge,"NF-kB reporter, cytokine release, rescue of co-culture toxicity",CHEMBL5919,0,https:
|
| PRKN,mitochondrial quality control,E3 ligase and recessive PD gene,64.0,strong validation target,PRKN knockout iPSC dopaminergic neurons,"mitophagy reporter, ubiquitination, mitochondrial stress survival",,0,https:
|
|
|